U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465627) titled 'Vessel Recoil in Specific CLTI Populations' on March 06.
Brief Summary: Chronic limb threatening ischemia (CLTI) represents the most advanced stage of peripheral arterial disease (PAD) and is characterized by ischemic rest pain, non-healing wounds, or ischemic gangrene. High-risk PAD populations including patients with end-stage renal disease and or diabetes also experience worse outcomes with significantly increased rates of amputation and mortality.
Although some patients with PAD are best treated with a combination of medical management, exercise and lifestyle modification, revascularization is indicated in those with advanced ...